about
The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetesThe environment and the origins of islet autoimmunity and Type 1 diabetesMaternal microchimerism: friend or foe in type 1 diabetes?Novel diabetes autoantibodies and prediction of type 1 diabetesImmune therapy in type 1 diabetes mellitusEvidence that low-grade systemic inflammation can induce islet dysfunction as measured by impaired calcium handling.Advances in understanding autoimmune pituitary disease: standardized methods for autoantibody detection.Myelin Oligodendrocyte Glycoprotein: Deciphering a Target in Inflammatory Demyelinating Diseases.Prevalence and clinical characteristics of lower limb atherosclerotic lesions in newly diagnosed patients with ketosis-onset diabetes: a cross-sectional studyAltered B cell signalling in autoimmunity.Extrapancreatic autoantibody profiles in type I diabetesThe association between the PTPN22 1858C>T variant and type 1 diabetes depends on HLA risk and GAD65 autoantibodies.Kinetics of the post-onset decline in zinc transporter 8 autoantibodies in type 1 diabetic human subjects.HLA class II alleles susceptibility markers of type 1 diabetes fail to specify phenotypes of ketosis-prone diabetes in adult Tunisian patients.Contribution of antibodies against IA-2β and zinc transporter 8 to classification of diabetes diagnosed under 40 years of age.High plasma levels of islet amyloid polypeptide in young with new-onset of type 1 diabetes mellitus.Characteristics of pediatric diabetic ketoacidosis patients in Saudi Arabia.Low risk HLA-DQ and increased body mass index in newly diagnosed type 1 diabetes children in the Better Diabetes Diagnosis study in Sweden.Loss of intra-islet CD20 expression may complicate efficacy of B-cell-directed type 1 diabetes therapiesAntigen-specific blocking of CD4-specific immunological synapse formation using BPI and current therapies for autoimmune diseases.Established and emerging biomarkers for the prediction of type 1 diabetes: a systematic review.Multiple microRNAs within the 14q32 cluster target the mRNAs of major type 1 diabetes autoantigens IA-2, IA-2β, and GAD65.Surface plasmon resonance reveals a different pattern of proinsulin autoantibodies concentration and affinity in diabetic patients.Etiopathogenesis of insulin autoimmunity.Heterogeneity and Lobularity of Pancreatic Pathology in Type 1 Diabetes during the Prediabetic PhaseA Jekyll and Hyde Profile: Type 1 Interferon Signaling Plays a Prominent Role in the Initiation and Maintenance of a Persistent Virus Infection.Pancreatic duodenal homeobox 1 protein is a novel beta-cell-specific autoantigen for type I diabetes.The course of diabetes in children, adolescents and young adults: does the autoimmunity status matter?Islet cell autoantibodies in African patients with Type 1 and Type 2 diabetes in Dar es Salaam Tanzania: a cross sectional study.SENP1-mediated NEMO deSUMOylation in adipocytes limits inflammatory responses and type-1 diabetes progressionAntigen presentation of detergent-free glutamate decarboxylase (GAD65) is affected by human serum albumin as carrier protein.Autoimmunity in gestational diabetes mellitus in Sardinia: a preliminary case-control reportIncidence of Type 1 Diabetes among Children and Adolescents in Italy between 2009 and 2013: The Role of a Regional Childhood Diabetes Registry.Mediators and mechanisms of pancreatic beta-cell death in type 1 diabetes.Autoimmunity against INS-IGF2 protein expressed in human pancreatic islets.The role of adipose-derived inflammatory cytokines in type 1 diabetesAn important minority of prediabetic first-degree relatives of type 1 diabetic patients derives from seroconversion to persistent autoantibody positivity after 10 years of age.Targeting erythrocyte carbonic anhydrase and (18)O-isotope of breath CO2 for sorting out type 1 and type 2 diabetes.No Contribution of GAD-65 and IA-2 Autoantibodies around Time of Diagnosis to the Increasing Incidence of Juvenile Type 1 Diabetes: A 9-Year Nationwide Danish Study.Comparison of three assays for the detection of GAD65Ab-specific anti-idiotypic antibodies.
P2860
Q24675521-CD547DEE-3FA4-49BD-8C4D-4835082BC759Q26827633-4806EF90-E98F-442A-8802-CBAA84A385CAQ26851151-33596D4C-65A3-48E6-9DE9-73E475D7DB55Q27016130-BC220B2D-530D-41EA-9781-74B2F234FE63Q28282846-A5379111-2F1C-45FA-9557-92710BD6EFD5Q30430981-C5E9D636-F492-4D62-B83B-63DDEBB08E9CQ33568973-0650E486-252D-4028-A1E7-BC9758201CC8Q33645795-ABF2026E-A5F7-4D32-AB12-1767FCBF95A9Q33745758-7F18A1D4-6CAF-4CEC-A92A-E43173FEB0C3Q33924642-1A6F028E-ACAE-45A1-B2CD-008A6E516709Q34428374-7222FF21-D4A8-4438-B848-5FFF2424399AQ34607188-82DB421B-13AD-4D28-8494-F0A568F6394DQ34630695-00C8B4FE-E470-4D91-9FD7-4D21F39C669DQ34713928-8EDA772F-C3F3-47A4-A659-BA6FE73AD013Q35123421-97467F32-FFED-4283-8599-610CCDC6942EQ35132136-ED64DA44-38BD-4FB3-983C-3B23BD7E8608Q35183783-05A3FF6F-9AA3-48B3-950F-0FBFC7751CC5Q35341810-9D75AB10-99E9-4790-AF2F-EEB767782EC1Q35405281-874BE3E3-166F-46BC-A2CA-79210A9BD01CQ35637379-B82FC3E7-7FEB-42D6-91A2-22F85E6C17B2Q35674747-49E80B22-6953-4E68-B0DB-6C91E7B0E5ECQ35684542-53E317EB-E231-43D5-913C-942EEEBD3739Q35839894-909692AF-867A-4507-B86C-664016DBB2D9Q35910119-088398D8-32F8-4C26-9775-72B119C29DCCQ35932766-76431548-EECB-41CF-B675-D51DBFFEE8DDQ36071907-EA49E0DA-76EB-488D-8388-5DBE1A8F8EDAQ36126782-463DD71F-88EE-47F9-AAB5-E23244CBC4CAQ36192161-7A84715D-B6DF-4EDE-B4CC-8E20509516F5Q36285920-C34464C5-C16F-466E-94D3-5F0E11E48B87Q36325236-B24EFE4F-2C13-45CB-B2D3-E9E67FC0FDDEQ36742048-D38DBBC7-9FC9-4CFE-AB4B-9CAA1CCD2DCBQ36761582-4AEFBFEC-20CF-440B-9CA3-2CD207A60765Q36764575-2C37E618-83D5-42F6-8E54-66A5AF844307Q37148316-A5FE6520-11E7-47A5-9DE6-56D0476112C7Q37213887-356A8271-9952-490E-8389-DFAE63FC40CFQ37238016-E7DEB6BF-9B4D-444F-ACC7-AB6D92A95036Q37261014-73BCA278-EB7D-401D-8455-1B4804EBF7A8Q37355525-A11A11E9-C542-4AB9-B830-69250C682291Q37368891-FDBBED9C-586E-40E2-9D5C-9EFB515CD007Q37482636-5DC776AA-51DA-4F45-8867-41ECC9F2D184
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Autoantibodies in diabetes.
@ast
Autoantibodies in diabetes.
@en
type
label
Autoantibodies in diabetes.
@ast
Autoantibodies in diabetes.
@en
prefLabel
Autoantibodies in diabetes.
@ast
Autoantibodies in diabetes.
@en
P2093
P1433
P1476
Autoantibodies in diabetes.
@en
P2093
Ake Lernmark
Catherine Pihoker
Lisa K Gilliam
P304
P356
10.2337/DIABETES.54.SUPPL_2.S52
P407
P478
54 Suppl 2
P577
2005-12-01T00:00:00Z